Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database

References

• Piek MW, de Boer JP, van Duijnhoven F, van der Wal JE, Vriens M, van Leeuwaarde RS, et al. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice. BMC Cancer. 2022;22(1):1018. doi:10.1186/s12885-022-10069-6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu Y, Liu F, Fu L, Tong Z. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer. Oncotarget. 2016;7(32):52450–52459. doi:10.18632/oncotarget.9547.
   PubMedGoogle Scholar
• Stein M, Bartal A, Kuten A, Loberant N, Hershkovitz R, Masalcha H, et al. Multiple primary thyroid and breast cancer in Israel, 1960-1976. S Afr Med J. 1989;76(12):664–666.
   PubMed Web of Science ®Google Scholar
• Karaköse M, Çordan İ, Can M, Kocabaş M, Kulaksızoğlu M, Karakurt F. Incidence of second primary malignancies in patients with thyroid cancer in the Turkish population. Turk J Med Sci. 2019;49(5):1529–1533. doi:10.3906/sag-1903-104.
   PubMed Web of Science ®Google Scholar
• Van Fossen VL, Wilhelm SM, Eaton JL, McHenry CR. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies. Ann Surg Oncol. 2013;20(4):1341–1347. doi:10.1245/s10434-012-2718-3.
   PubMed Web of Science ®Google Scholar
• Li CI, Rossing MA, Voigt LF, Daling JR. Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States). Cancer Causes Control. 2000;11(9):805–811. doi:10.1023/a:1008942616092.
   PubMed Web of Science ®Google Scholar
• Joseph KR, Edirimanne S, Eslick GD. The association between breast cancer and thyroid cancer: a meta-analysis. Breast Cancer Res Treat. 2015;152(1):173–181. doi:10.1007/s10549-015-3456-6.
   PubMed Web of Science ®Google Scholar
• An JH, Hwangbo Y, Ahn HY, Keam B, Lee KE, Han W, et al. A possible association between thyroid cancer and breast cancer. Thyroid. 2015;25(12):1330–1338. doi:10.1089/thy.2014.0561.
   PubMed Web of Science ®Google Scholar
• Evans HS, Lewis CM, Robinson D, Bell CM, Møller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001;84(3):435–440. doi:10.1054/bjoc.2000.1603.
   PubMed Web of Science ®Google Scholar
• Jung HK, Park S, Kim NW, Lee JE, Kim Z, Han SW, et al. Development of second primary cancer in Korean breast cancer survivors. Ann Surg Treat Res. 2017;93(6):287–292. doi:10.4174/astr.2017.93.6.287.
   PubMed Web of Science ®Google Scholar
• Consorti F, Di Tanna G, Milazzo F, Antonaci A. Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer. World J Surg Oncol. 2011;9(1):88. doi:10.1186/1477-7819-9-88.
   PubMedGoogle Scholar
• Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I, et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid. 2007;17(12):1277–1288. doi:10.1089/thy.2007.0171.
   PubMed Web of Science ®Google Scholar
• Jin YJ, Kwon MJ, Kim JH, Kim JH, Choi HG. Association between thyroid cancer and breast cancer: two longitudinal follow-up studies using a national health screening cohort. J Pers Med. 2022;12(2):133. doi:10.3390/jpm12020133.
   PubMed Web of Science ®Google Scholar
• Lee E, Jeong SH, Nam CM, Jun JK, Park EC. Role of breast cancer screening in the overdiagnosis of thyroid cancer: results from a cross-sectional nationwide survey. BMC Womens Health. 2023;23(1):64. doi:10.1186/s12905-023-02205-6.
   PubMed Web of Science ®Google Scholar
• Wang H, Li S, Shi J, Feng C, Wang Y, Zhang F. Unbalanced bidirectional causal association between thyroid cancer and ER-positive breast cancer: should we recommend screening for thyroid cancer in breast cancer patients? BMC Genomics. 2023;24(1):762. doi:10.1186/s12864-023-09854-9.
   PubMed Web of Science ®Google Scholar
• Zervoudis S, Iatrakis G, Markja A, Tsatsaris G, Bothou A, von Tempelhoff GF, et al. Risk factors of synchronous breast and thyroid cancer: a controlled multicenter study and review of the literature. Mater Sociomed. 2021;33(4):298–303. doi:10.5455/msm.2021.33.298-303.
   PubMedGoogle Scholar
• Bolf EL, Sprague BL, Carr FE. A linkage between thyroid and breast cancer: a common etiology? Cancer Epidemiol Biomarkers Prev. 2019;28(4):643–649. doi:10.1158/1055-9965.EPI-18-0877.
   PubMed Web of Science ®Google Scholar
• Li S, Yang J, Shen Y, Zhao X, Zhang L, Wang B, et al. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database. BMC Public Health. 2019;19(1):1592. doi:10.1186/s12889-019-7947-y.
   PubMed Web of Science ®Google Scholar
• Liu X, Wu Z, Lin E, Li W, Chen Y, Sun X, et al. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy. Clin Nutr. 2019;38(4):1853–1860. doi:10.1016/j.clnu.2018.07.015.
   PubMed Web of Science ®Google Scholar
• Mahal BA, Yang DD, Wang NQ, Alshalalfa M, Davicioni E, Choeurng V, et al. Clinical and genomic characterization of low-prostate-specific antigen, high-grade prostate cancer. Eur Urol. 2018;74(2):146–154. doi:10.1016/j.eururo.2018.01.043.
   PubMed Web of Science ®Google Scholar
• Motyer AJ, McKendry C, Galbraith S, Wilson SR. LASSO model selection with post-processing for a genome-wide association study data set. BMC Proc. 2011;5(Suppl 9):S24. doi:10.1186/1753-6561-5-S9-S24.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Huang NS, Chen XX, Wei WJ, Mo M, Chen JY, Ma B, et al. Association between breast cancer and thyroid cancer: a study based on 13 978 patients with breast cancer. Cancer Med. 2018;7(12):6393–6400. doi:10.1002/cam4.1856.
   PubMed Web of Science ®Google Scholar
• Muller I, Pinchera A, Fiore E, Belardi V, Rosellini V, Giustarini E, et al. High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest. 2011;34(5):349–352. doi:10.1007/BF03347458.
   PubMed Web of Science ®Google Scholar
• Liu L, Shi J, Mao F, Wei J, Fu D, Zhang J. Synchronous primary cancers of the thyroid and breast: a case report and review of the literature. Oncol Lett. 2015;9(1):351–354. doi:10.3892/ol.2014.2625.
   PubMed Web of Science ®Google Scholar
• Arer İM, Yabanoğlu H, Kuş M, Akdur A, Avcı T. Retrospective analysis of patients with synchronous primary breast and thyroid carcinoma. Eur J Breast Health. 2018;14(2):80–84. doi:10.5152/ejbh.2018.3853.
   PubMed Web of Science ®Google Scholar
• Hong C, Zheng Y, Geng R, Hu H, Zhong Y, Guan Q, et al. Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data. Ann Transl Med. 2022;10(13):742–742. doi:10.21037/atm-21-5400.
   PubMed Web of Science ®Google Scholar
• Lee J, Park S, Kim S, Kim J, Ryu J, Park HS, et al. Characteristics and survival of breast cancer patients with multiple synchronous or metachronous primary cancers. Yonsei Med J. 2015;56(5):1213–1220. doi:10.3349/ymj.2015.56.5.1213.
   PubMed Web of Science ®Google Scholar
• Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol. 2012;19(6):1887–1896. doi:10.1245/s10434-011-2193-2.
   PubMed Web of Science ®Google Scholar
• Chiappa C, Rovera F, Rausei S, Del Ferraro S, Fachinetti A, Lavazza M, et al. Breast cancer and thyroid diseases: analysis of 867 consecutive cases. J Endocrinol Invest. 2017;40(2):179–184. doi:10.1007/s40618-016-0543-4.
   PubMed Web of Science ®Google Scholar
• Park CM, Lee YD, Oh EM, Kim KI, Park HK, Ko KP, et al. The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients: comparison with ordinary thyroid cancer. Ann Surg Treat Res. 2014;86(4):169–176. doi:10.4174/astr.2014.86.4.169.
   PubMed Web of Science ®Google Scholar
• Han M, Wang Y, Jin Y, Zhao X, Cui H, Wang G, et al. Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis. Front Endocrinol (Lausanne)). 2022;13:984593. doi:10.3389/fendo.2022.984593.
   PubMedGoogle Scholar
• Zhai J, Kong XY, Fang Y, Wang J. Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer. Zhonghua Zhong Liu Za Zhi. 2021;43(12):1287–1291. doi:10.3760/cma.j.cn112152-20210621-00461.
   PubMedGoogle Scholar
• Kim JH, Kang I, Nam S, Park HS, Park S, Jeong JJ, et al. Comparison of characteristics in patients with both thyroid and breast cancer: Based on order of incidence. Korean J Clin Oncol. 2017;13(1):1–9. doi:10.14216/kjco.17001.
   Google Scholar
• Zhao X, Yang G, Zhang W, Dong Q, Yang Q. Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer. Endocrine. 2022;76(2):385–394. doi:10.1007/s12020-022-02999-9.
   PubMed Web of Science ®Google Scholar
• Jeon YW, Gwak HG, Lim ST, Schneider J, Suh YJ. Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann Surg Oncol. 2019;26(9):2952–2958. doi:10.1245/s10434-019-07482-w.
   PubMed Web of Science ®Google Scholar
• Dobrinja C, Pastoricchio M, Troian M, Da Canal F, Bernardi S, Fabris B, et al. Partial thyroidectomy for papillary thyroid microcarcinoma: is completion total thyroidectomy indicated? Int J Surg. 2017;41 Suppl 1 (Suppl 1):S34–S39. doi:10.1016/j.ijsu.2017.02.012.
   PubMedGoogle Scholar
• Grantzau T, Overgaard J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients. Radiother Oncol. 2016;121(3):402–413. doi:10.1016/j.radonc.2016.08.017.
   PubMed Web of Science ®Google Scholar
• Tran TV, Rubino C, Allodji R, Andruccioli M, Bardet S, Diallo I, et al. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. Br J Cancer. 2022;127(12):2118–2124. doi:10.1038/s41416-022-01982-5.
   PubMed Web of Science ®Google Scholar